CrystalsFirst Company Contacts

CrystalsFirst's MAGNET platform overcomes current limitations of small molecule drug discovery. Our proprietary structural biology technology detects molecular magnets and generative AI/Machine Learning identifies novel molecules and druggable binding pockets for difficult targets. Our MAGNET Platform is a unique and... Read More

Contacts

Country

Germany

City

Hamburg

Headquarters

Hamburg, DE

Profile

Founded

2018

Industry

Biotechnology Research

Size

11 - 50

Specialties

drug discovery, lead discovery, hit finding, structural biology, fragment-based drug discovery, FBDD, FBLD, fragment-based lead discovery, crystallography, lead optimization, generative AI, machine learning, virtual screening

Funding

Total Rounds

Last Round

Sun Jul 31 2022

Last Round Series

Non equity assistance

Last Round Raised

No Data

CrystalsFirst Company Contacts

CrystalsFirst Add to my CRM

CrystalsFirst